Skip to content

BME Announces Agreement to Divest Austrian Subsidiary Quester

News release 02 June 2025

Today, BME announces the signing of an agreement to divest its shares in Quester, its Austrian subsidiary, to Callista. This decision is in line with BME’s strategy to focus on its core markets with the highest potential for profitable growth.

Quester has been part of our Group for many years, and their strong market position and widely recognized brand will surely enable them to grow in this market. For BME, we will continue to focus our efforts on further expanding our presence in key European markets which have the highest growth and value creation potential for us. We are confident that under Callista’s ownership, Quester will continue to strengthen its position in the Austrian market.” – Remco Teulings (Group CEO)

The transaction is subject to regulatory approval and necessary clearances.

Financial details of the transaction will not be disclosed.